Faculty

Amanda Phipps

Associate Professor, Epidemiology
Associate/Vice Chair - Director, Epidemiology

206-667-7741

Education

PhD Epidemiology, University of Washington, 2010
MPH Epidemiology, University of California (Berkeley), 2003
BA Biological Sciences, Northwestern University, 2001

Contact

206-667-7741

Box 351619
Department of Epidemiology
Hans Rosling Center for Population Health, 875
Seattle, WA 98195

Research Areas

Research Interests

Dr. Phipps's research interests span the fields of cancer epidemiology, molecular epidemiology, and clinical epidemiology. Her current projects focus on the relationship between modifiable lifestyle factors (e.g., smoking, obesity) and survival in individuals with biologically-distinct subtypes of colorectal cancer, and the impact of sleep and sleep disorders on cancer incidence and survival. She also has an interest in molecular subtypes of breast cancer, particularly in risk factors for the poor-prognosis triple-negative subtype of breast cancer.

Recent Publications (PubMed)

Multiple polygenic score approach in colorectal cancer risk prediction.
(2025 Oct 30)
Sci Rep 15(1): 38006
Jiang SJ, Thomas M, Rosenthal EA, Phipps AI, Sakoda LC, van Duijnhoven FJB, Pellatt AJ, Avery CL, Berndt SI, Bishop DT, Castellví-Bel S, Chan AT, Grant RC, Gignoux C, Gsur A, Gunter MJ, Haiman CA, Hoffmeister M, Jarvik GP, Jenkins MA, Keku TO, Küry S, Lee JK, Marchand LL, Moreno V, Newcomb PA, Newton CC, Ogino S, Palmer JR, Pearlman R, Qu C, Schoen RE, Um CY, Van Guelpen B, Visvanathan K, Vymetalkova V, White E, Woods MO, Platz EA, Brenner H, Corley DA, Vogelaar IL, Hsu L, Peters U
Investigating the causal effect of potential therapeutic agents for colorectal cancer prevention: a Mendelian randomization analysis.
(2025 Oct 14)
Cancer Epidemiol Biomarkers Prev
Fryer E, Bishop DT, Campbell PT, Chan AT, Le Marchand L, Li CI, Moreno V, Gunter MJ, Phipps AI, Grant RC, Schmit SL, Martin RM, Yarmolinsky J, Haycock P
Utility of quantitative pathologic analysis of pT1 colorectal carcinomas to improve prediction of lymph node metastasis.
(2025 Oct 8)
Virchows Arch
Nayak P, Kosiorek H, Pai RK, Shivji S, Hagen CE, Graham RP, Buchanan DD, Jenkins MA, Phipps AI, Le Marchand L, Wu C, Samadder NJ, Swallow CJ, Gallinger SJ, Grant RC, Westerling-Bui T, Conner J, Cyr DP, Kirsch R, Pai RK
Investigating the relationship of plasma microRNAs and colorectal cancer risk using genetic evidence.
(2025 Oct 2)
BMC Med 23(1): 532
Bouras E, Papagiannopoulos CK, Mustafa R, Sobieski D, Schmit SL, Wu AH, Brenner H, Li CI, Chan AT, Pellatt AJ, Zheng W, Keku TO, Moreno V, Um CY, Van Guelpen B, Phipps AI, Pai RK, Lewis SJ, Martin RM, Gunter MJ, Peters U, Dehghan A, Tsilidis KK
Physical activity and molecular subtypes of colorectal cancer: a pooled observational analysis and Mendelian randomization study.
(2025 Nov 3)
JNCI Cancer Spectr 9(6):
Chalitsios CV, Markozannes G, Aglago EK, Berndt SI, Buchanan DD, Campbell PT, Cao Y, Chan AT, Dimou N, Drew DA, French AJ, Georgeson P, Giannakis M, Gruber SB, Gunter MJ, Harrison TA, Hoffmeister M, Hsu L, Huang WY, Hullar MAJ, Huyghe JR, Lynch BM, Moreno V, Murphy N, Newton CC, Nowak JA, Obón-Santacana M, Ogino S, Qu C, Schmit SL, Steinfelder RS, Sun W, Thomas CE, Toland AE, Trinh QM, Ugai T, Um CY, Guelpen BV, Zaidi SH, Schoen RE, Woods MO, Brenner H, Andreson L, Pellatt AJ, Peters U, Phipps AI, Tsilidis KK
Show complete publication list